Summary
Updated Aug 31, 2026
Sandra McDonough is Director of Northwest Natural Holding Co (NWN). 6 SEC Form 4 filings on record going back to 2024, most recently on 7 August 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Sandra McDonough has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sandra McDonough files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Hugo Anderson - $2.16M of NWN open-market activity in the last 12 months
- David A. Weber - $89K of NWN open-market activity in the last 12 months
- Justin Palfreyman - $60K of NWN open-market activity in the last 12 months
- Peter J. Bragdon - $20K of NWN open-market activity in the last 12 months
- Kimberly Heiting Rush - $61 of NWN open-market activity in the last 12 months
- Joseph S. Karney - $60 of NWN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sandra McDonough?
Sandra McDonough is a corporate insider, tracked as Director of Northwest Natural Holding Co (NWN). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sandra McDonough submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Sandra McDonough's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sandra McDonough and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial